Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29

Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29

Epidermal growth receptor HER2/neu is still of great interest, the overexpression of which is most often observed in patients with breast cancer and accounts for 15–20 % of cases. Present methods of HER2/neu determination have a number of significant drawbacks. In recent years, alternative framework...

Full description

Bibliographic Details
Main Authors:	O. D. Bragina, V. I. Chernov, A. A. Medvedeva, R. V. Zelchan, M. S. Larkina, S. M. Deyev, V. M. Tolmachev
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Siberian Branch Publishing House 2020-08-01
Series:	Сибирский научный медицинский журнал
Subjects:	breast cancer darpin9_29 target radionuclide diagnostic
Online Access:	https://sibmed.elpub.ru/jour/article/view/450

Similar Items

Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair
by: Ludmila G. Alekseeva, et al.
Published: (2024-02-01)

Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with <sup>99m</sup>Tc for Radionuclide Imaging of HER2 Expression in Cancer
by: Mariia Larkina, et al.
Published: (2022-11-01)

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
by: Sergey M. Deyev, et al.
Published: (2021-07-01)

Direct In Vivo Comparison of <sup>99m</sup>Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
by: Vladimir Tolmachev, et al.
Published: (2022-12-01)

On the prevention of kidney uptake of radiolabeled DARPins
by: Mohamed Altai, et al.
Published: (2020-02-01)

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [<sup>99m</sup>Tc]Tc-ADAPT6 and [<sup>99m</sup>Tc]Tc-(HE)<sub>3</sub>-G3, for Imaging of HER2-Positive Breast Cancer
by: Olga Bragina, et al.
Published: (2023-06-01)

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu
by: Olga D. Bragina, et al.
Published: (2017-10-01)

Designing pLEX-LAMP-DARPin Lentiviral Vector for Exression of HER2 Targeted DARPin on Exosome Surface
by: Shabanali Khodashenas Limoni, et al.
Published: (2017-08-01)

DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice
by: Galina M. Proshkina, et al.
Published: (2021-10-01)

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model
by: Tianqi Xu, et al.
Published: (2023-02-01)

Synergistic Effect of the Combination of the Recombinant Toxin DARPin-LoPE and PDT against HER2-Positive Breast Cancer In Vitro
by: Liubov V. Krylova, et al.
Published: (2023-03-01)

Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy
by: Federica Gabriele, et al.
Published: (2023-05-01)

Comparative Analysis of the Clinical Use of 99mTechnetium-Labeled Recombinant Target Molecules in Different Dosages for the Radionuclide Diagnosis of Her2-Positive Breast Cancer
by: O. D. Bragina, et al.
Published: (2021-06-01)

Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using <sup>99m</sup>Tc-DARPinG3
by: O. D. Bragina, et al.
Published: (2023-01-01)

Protein interference applications in cellular and developmental biology using DARPins that recognize GFP and mCherry
by: Michael Brauchle, et al.
Published: (2014-11-01)

Momordica and Pycnogenol Can Tolerate Imazamox Induced Toxicity in L929 Cells Line: In Vitro Study
by: Ali Taghizadehghalehjoughi, et al.
Published: (2018-12-01)

DARPins recognizing mTFP1 as novel reagents for in vitro and in vivo protein manipulations
by: M. Alessandra Vigano, et al.
Published: (2018-11-01)

9.29J / 8.261J Introduction to Computational Neuroscience, Spring 2002
by: Seung, H. Sebastian
Published: (2002)

The production of the first functional antibody mimetic in higher plants: the chloroplast makes the DARPin G3 for HER2 imaging in oncology
by: Maryam Ehsasatvatan, et al.
Published: (2022-10-01)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-10-01)

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
by: Ya-feng Lv, et al.
Published: (2023-12-01)

Molecular Dynamics Simulations in Designing DARPins as Phosphorylation-Specific Protein Binders of ERK2
by: Vertika Gautam, et al.
Published: (2021-07-01)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
by: Lennard Karsten, et al.
Published: (2022-02-01)

Enucleated L929 mouse fibroblasts support invasion and multiplication of Shigella flexneri 5a
by: D. Yamamoto, et al.
Published: (2006-06-01)

The lyophilized chloroplasts store synthetic DARPin G3 as bioactive encapsulated organelles
by: Maryam Ehsasatvatan, et al.
Published: (2023-10-01)

Molecular Cloning of DARPins G3 in pET28b Expression Vector and Optimization of the Expression of This Protein in Escherichia Coli
by: Nadereh Bakhshandeh, et al.
Published: (2022-03-01)

Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)

The antimicrobial peptide gramicidin S alters proliferation and inhibits adhesion of L929 cell line fibroblasts
by: N. M. Alabedalkarim, et al.
Published: (2023-08-01)

Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin
by: Lukas Becker, et al.
Published: (2021-08-01)

EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT)
by: O. D. Bragina, et al.
Published: (2021-10-01)

Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts
by: I. V. Lyagoskin, et al.
Published: (2020-03-01)

Exploring rigid-backbone protein docking in biologics discovery: a test using the DARPin scaffold
by: Francis Gaudreault, et al.
Published: (2023-08-01)

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
by: Burcu Altıparmak Güleç, et al.
Published: (2021-07-01)

Photoprotective effects of Sargassum thunbergii on ultraviolet B-induced mouse L929 fibroblasts and zebrafish
by: Bei Chen, et al.
Published: (2022-05-01)

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-05-01)

Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
by: Evgeniya Sokolova, et al.
Published: (2019-05-01)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
by: Tianqi Xu, et al.
Published: (2021-08-01)

Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
by: P. August Schubiger, et al.
Published: (2004-10-01)

Characterization of Solidified Cement Bearing Organo-Clay after Adsorption of Perchlorate as a Surrogate of an Anionic Radionuclide
by: Akihiro INOUE, et al.
Published: (2017-10-01)

Quantitative Phase Imaging to Study the Effect of Sodium Dodecyl Surfactant on Adherent L929 Fibroblasts on Tissue Culture Plates
by: Sonthikan Sitthisang, et al.
Published: (2021-11-01)